SABCS Speakers

Dr Lim Wei Tching Faye Lynnette works at National Cancer Centre Singapore in the Division of Radiation Oncology as a Consultant BMedSci (Nottingham), MBBS (Nottingham), MRCP (UK), FRCR (Clinical Oncology)(UK). Her area of specialty is Radiation Oncology and sub-specialties are Breast, Hepato-Pancreato-Biliary, Upper Gastrointestinal, and Colorectal.

Hope S. Rugo, MD, FASCO, is professor of medicine in the Division of Hematology and Oncology at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, where she is also the director of Breast Oncology and Clinical Trials Education. Dr. Rugo joined the Breast Care Center in 1999 after a decade of experience at University of California San Francisco in malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer. She entered the field of breast cancer in order to incorporate novel therapies based on an understanding of the biology of cancer with excellent quality of care into the treatment of women with breast cancer.

Dr Lim Sue Zann is a Consultant in the Department of General Surgery, Singapore General Hospital. She graduated with Honours from the Faculty of Medicine, University of Malaya in 2008. She completed her specialty training in Singapore General Hospital and achieved specialist accreditation in 2017. At the same time, she became a Fellow of the Royal College of Surgeons of Edinburgh. Currently she is undergoing a fellowship in Advanced Breast Surgery within the SingHealth Duke-NUS Breast Centre and Department of Reconstructive and Aesthetic Surgery, Singapore General Hospital. She will further hone her skills in oncological and reconstructive breast surgery during this time. Dr Lim Sue Zann is actively involved in medical education. She is a Clinical Lecturer at NUS Yong Loo Lin School of Medicine and Physician Faculty Member at SingHealth General Surgery Residency Program. She received the Dean’s Award for Teaching Excellence from NUS Yong Loo Lin School of Medicine in 2013. Her research interests are in breast sarcoma and phyllodes tumours. She was awarded the Singapore General Hospital Research Grant in 2016 to further her work in these tumours. She has presented at surgical conferences and published papers on breast surgery.

Dr Shaheenah Dawood is a Consultant Medical Oncologist and Professor in Clinical Oncology in the United Arab Emirates. She was trained in medical oncology at McGill University Hospitals in Canada and subspecialized in breast cancer management at MD Anderson Cancer Center. During her training, she was awarded multiple scholar training awards besides ASCO merit awards. Dr Shaheenah has served as an editorial fellow at the New England Journal of Medicine and has an MPH from the Harvard School of Public Health. She has over 100 papers to her credit including 50 peer review original articles, 30 review articles, and 12 book chapters. Having served as a reviewer for multiple journals including the Journal of Clinical Oncology she is currently leading the oncology clinical trials program at Mediclinic City Hospital, Dubai. She also serves as President of Excellence in Oncology Care (EIOC) annual congress held in Dubai and is Co-Chair of the Asia Pacific Breast Cancer Summit (APBCS), Asia Pacific Gastrointestinal Cancer Summit (APGCS) ,the international BRCA forum (iBRCAf) and Young Women Forum (YWF) from over a decade.

Dr. Virginia G. Kaklamani is a professor of medicine in the division of hematology/oncology at UT Health San Antonio and is the leader of the Breast Cancer Program at UT Health San Antonio MD Anderson Cancer Center. Dr. Kaklamani completed her medical training with honors at the University of Athens and her residency in internal medicine at Newton-Wellesley Hospital in Boston. She completed her fellowship in hematology/oncology at Northwestern University. She also received a master of science degree in clinical investigation from Northwestern University. She was head of the Translational Breast Cancer Program at Northwestern University and co-director of Northwestern's cancer genetics program. Her research interests include studying high-risk families and identifying genetic mutations that are associated with an increased risk for breast, colon and prostate cancer. She has identified several genetic mutations related to obesity that increase the risk of breast cancer. Dr. Kaklamani is a clinical investigator with expertise in designing clinical trials with targeted agents.

Dr Wong Nan Soon is an oncologist practising at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. His subspecialty interests are in breast cancer and gastrointestinal cancer. He completed his advanced specialty training in general medical oncology in 2003, and subsequently a clinical fellowship subspecializing in breast medical oncology in Sunnybrook and Women’s Health Science Centre in Canada, where he trained under world-renowned breast oncologists including Professor Kathleen Pritchard. He was promoted to the position of consultant in 2006 and subsequently rose to the position of senior consultant and chief of the breast team in the department of medical oncology at National Cancer Centre, Singapore.